Rankings
▼
Calendar
TECX FY 2019 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena
TECX
Tectonic Therapeutic, Inc.
$634M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$850,000
Operating Income
-$76M
Net Income
-$73M
EPS (Diluted)
$-31.92
Cash Flow
Operating Cash Flow
-$68M
Free Cash Flow
-$69M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$201M
Total Liabilities
$15M
Stockholders' Equity
$186M
Cash & Equivalents
$187M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$850,000
-$380,000
-123.7%
Operating Income
-$76M
-$46M
-63.9%
Net Income
-$73M
-$46M
-57.4%
← Q4 2018
All Quarters
Q1 2019 →